CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex. (2019)

First Author: Schmidt L

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41375-019-0382-3

PubMed Identifier: 30679799

Publication URI: http://europepmc.org/abstract/MED/30679799

Type: Journal Article/Review

Volume: 33

Parent Publication: Leukemia

Issue: 7

ISSN: 0887-6924